Abstract: Described herein are embodiments of an electronic gas emission management system. The system accepts values for a plurality of emission sources of a portfolio according to native input formats for the plurality of emission sources. The system translates the native input formats into a first format, wherein the first format allows comparing emissions among the plurality of emission sources. The system accepts user input specifying a target emission for the portfolio. The system determines values for one or more parameters using the emission values for the plurality of emission sources stored in the first format and generates a display for the portfolio based on the parameter(s).

Abstract: Utilizing electronic prescriptions (eRx), ETASU enforcement for a drug associated with a REMS may be performed at a more natural point in prescription processing. By incorporating an encrypted REMS Dispense Authorization (RDA) into eRxs, an eRx router may validate various elements of the eRx against encrypted data elements and thereby verify that any ETASUs required by a REMS for a prescribed drug have been complied with. As a result, only validated eRx are passed from the eRx router to pharmacies for dispensing, reducing manual intervention to confirm compliance. Information necessary to perform validation may be communicated to the eRx router by a Trusted Central RDA Authority (TCRA), and may include decryption keys, prescriber authorization data, and appropriate validation check algorithms.

Abstract: Utilizing electronic prescriptions (eRx), ETASU enforcement for a drug associated with a REMS may be performed at a more natural point in prescription processing. By incorporating an encrypted REMS Dispense Authorization (RDA) into eRxs, an eRx router may validate various elements of the eRx against encrypted data elements and thereby verify that any ETASUs required by a REMS for a prescribed drug have been complied with. As a result, only validated eRx are passed from the eRx router to pharmacies for dispensing, reducing manual intervention to confirm compliance. Information necessary to perform validation may be communicated to the eRx router by a Trusted Central RDA Authority (TCRA), and may include decryption keys, prescriber authorization data, and appropriate validation check algorithms.

Abstract: One aspect of the present disclosure relates to a breast implant sizer assembly for accurately sizing surgically implantable breast implants prior to implantation. The breast implant sizer assembly can include an inflatable, flexible shell containing an adjustable volume of liquid and a valve assembly, once filled with liquid, that is associated with the shell and configured like an anatomically correct nipple. The breast implant sizer assembly can have a size, shape, and weight that mimics the size, shape, and weight of a breast implant. In addition, the breast implant sizer assembly is disposable, intended for single use by a patient, allows for use in the home and everyday settings, and provides accurate, actionable information to a surgeon or other medical professional in regards to selecting actual breast implant sizes for clinical use.

Abstract: One aspect of the present disclosure relates to a breast implant sizer assembly for accurately sizing surgically implantable breast implants prior to implantation. The breast implant sizer assembly can include an inflatable, flexible shell containing an adjustable volume of liquid and a valve assembly, once filled with liquid, that is associated with the shell and configured like an anatomically correct nipple. The breast implant sizer assembly can have a size, shape, and weight that mimics the size, shape, and weight of a breast implant. In addition, the breast implant sizer assembly is disposable, intended for single use by a patient, allows for use in the home and everyday settings, and provides accurate, actionable information to a surgeon or other medical professional in regards to selecting actual breast implant sizes for clinical use.